HIV/AIDS Clinical Trials Networks

The NIAID HIV/AIDS Clinical Trials Networks have been designed to address NIAID’s five HIV/AIDS scientific priorities.

The Networks inlcude:

NIAID’s five HIV/AIDS scientific priorities are:

  1. Therapeutics for HIV/AIDS and HIV-associated infections in adults (including HIV cure, as well as co-occurring noninfectious and infectious diseases, including hepatitis and tuberculosis) (ACTG)
  2. HIV/AIDS and HIV-associated infections in children and mothers (IMPAACT)
  3. Integrated strategies to prevent HIV infection (HPTN)
  4. Vaccines to prevent HIV infection (HVTN)
  5. Microbicides to prevent HIV infection (MTN)
Events

Each network holds two to three large meetings per year.

Content last reviewed on November 17, 2017